Related references
Note: Only part of the references are listed.MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling
Bo Tang et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway
Yilan Wu et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2018)
Long non-coding RNA FEZF1-AS1 promotes cell growth in multiple myeloma via miR-610/Akt3 axis
Qian-yu Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
The emerging role of exosome-derived non-coding RNAs in cancer biology
Qing Fan et al.
CANCER LETTERS (2018)
Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression
Li Chen et al.
CELL CYCLE (2018)
Serum level of long noncoding RNA H19 as a diagnostic biomarker of multiple myeloma
Yafang Pan et al.
CLINICA CHIMICA ACTA (2018)
LncRNA PRAL is closely related to clinical prognosis of multiple myeloma and the bortezomib sensitivity
Gongwei Xiao et al.
EXPERIMENTAL CELL RESEARCH (2018)
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
Nicola Amodio et al.
LEUKEMIA (2018)
Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma
Mehmet Kemal Samur et al.
LEUKEMIA (2018)
Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma
Yi Hu et al.
LEUKEMIA (2018)
Exosome-mediated transfer of IncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis
Bingzong Li et al.
ONCOGENE (2018)
Long Noncoding RNA in Cancer: Wiring Signaling Circuitry
Chunru Lin et al.
TRENDS IN CELL BIOLOGY (2018)
The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro
Qian Cheng et al.
ACTA PHARMACOLOGICA SINICA (2018)
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
Muhammad S. Beg et al.
INVESTIGATIONAL NEW DRUGS (2017)
Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma
Y. Qin et al.
LEUKEMIA (2017)
Non-coding RNAs as drug targets
Masayuki Matsui et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Deregulated expression of long non-coding RNA UCA1 in multiple myeloma
Lenka Sedlarikova et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
Seung-Hyun Jung et al.
HAEMATOLOGICA (2017)
LncRNA MALAT-1 Elevates HMGB1 to Promote Autophagy Resulting in Inhibition of Tumor Cell Apoptosis in Multiple Myeloma
Da Gao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Role of epigenetics-microRNA axis in drug resistance of multiple myeloma
Nasrin Rastgoo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant
Ming J. Poi et al.
MOLECULAR CARCINOGENESIS (2017)
Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell
Alboukadel Kassambara et al.
NUCLEIC ACIDS RESEARCH (2017)
Long Noncoding RNA CRNDE Promotes Multiple Myeloma Cell Growth by Suppressing miR-451
Yi-Bin Meng et al.
ONCOLOGY RESEARCH (2017)
Exosomes: Therapy delivery tools and biomarkers of diseases
Lucio Barile et al.
PHARMACOLOGY & THERAPEUTICS (2017)
The role of exosomes in cancer metastasis
Teresa Bernadette Steinbichler et al.
SEMINARS IN CANCER BIOLOGY (2017)
LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma
Nan Yang et al.
CELL DEATH & DISEASE (2017)
LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression
Yueli Gu et al.
ONCOTARGET (2017)
Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
Seung-Hyun Jung et al.
HAEMATOLOGICA (2017)
Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of miR-21
Ping Liu et al.
JOURNAL OF CANCER (2017)
Multiple Myeloma-Derived Exosomes Regulate the Functions of Mesenchymal Stem Cells Partially via Modulating miR-21 and miR-146a
Qian Cheng et al.
STEM CELLS INTERNATIONAL (2017)
Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-kB axis
Elisabetta Vulpis et al.
ONCOIMMUNOLOGY (2017)
Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma
Muneyoshi Futami et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum
Xianjuan Shen et al.
CANCER BIOMARKERS (2017)
Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma
Hiroshi Handa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma
Shotaro Tatekawa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Long Noncoding RNA and Cancer: A New Paradigm
Arunoday Bhan et al.
CANCER RESEARCH (2017)
Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma
Xianjuan Shen et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Prognostic role of circulating exosomal miRNAs in multiple myeloma
Salomon Manier et al.
BLOOD (2017)
miRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor
Xianjuan Shen et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2016)
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
Annamaria Gulla et al.
CLINICAL CANCER RESEARCH (2016)
Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity
Kim De Veirman et al.
CANCER LETTERS (2016)
MicroRNA-433 Dampens Glucocorticoid Receptor Signaling, Impacting Circadian Rhythm and Osteoblastic Gene Expression
Spenser S. Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Current Controversies in the Management of Myeloma Bone Disease
Rebecca Silbermann et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay
Maria Pia Abruzzese et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma
Nicola Amodio et al.
MOLECULAR CANCER THERAPEUTICS (2016)
A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle
Benjamin R. Nelson et al.
SCIENCE (2016)
The Emerging Function and Mechanism of ceRNAs in Cancer
Yunfei Wang et al.
TRENDS IN GENETICS (2016)
Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
Li Zhang et al.
ONCOTARGET (2016)
Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors
Huiyuan Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Basic biology and therapeutic implications of lncRNA
O. Khorkova et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
Jian-Jun Zhao et al.
CANCER RESEARCH (2015)
A Micropeptide Encoded by a Putative Long Noncoding RNA Regulates Muscle Performance
Douglas M. Anderson et al.
CELL (2015)
The Role of Exosomes in Breast Cancer
Michelle C. Lowry et al.
CLINICAL CHEMISTRY (2015)
miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2
Martina Porstner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma
Kwan Yeung Wong et al.
MOLECULAR CANCER (2015)
Downregulation of MicroRNA-152 contributes to high expression of DKK1 in multiple myeloma
Yinyin Xu et al.
RNA BIOLOGY (2015)
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts
Maria Rita Pitari et al.
ONCOTARGET (2015)
Targeting the bone marrow microenvironment in multiple myeloma
Yawara Kawano et al.
IMMUNOLOGICAL REVIEWS (2015)
piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma
H. Yan et al.
LEUKEMIA (2015)
Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells
Jinheng Wang et al.
BLOOD (2014)
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1
Tomohiro Umezu et al.
BLOOD (2014)
MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression
Shih-Feng Cho et al.
BMC CANCER (2014)
The panorama of miRNA-mediated mechanisms in mammalian cells
Anna Stroynowska-Czerwinska et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma
Shu Yang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Activation of LTBP3 Gene by a Long Noncoding RNA (lncRNA) MALAT1 Transcript in Mesenchymal Stem Cells from Multiple Myeloma
Bingzong Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
MicroRNA theragnostics for the clinical management of multiple myeloma
N. Ahmad et al.
LEUKEMIA (2014)
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
Nicola Amodio et al.
CELL CYCLE (2013)
Contribution of microRNA 24-3p and Erk1/2 to interleukin-6-mediated plasma cell survival
Jessica Gabler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease
Marco Rossi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression
Aldo M. Roccaro et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
C. I. Jones et al.
BRITISH JOURNAL OF CANCER (2012)
Frequent PVT1 Rearrangement and Novel Chimeric Genes PVT1-NBEA and PVT1-WWOX Occur in Multiple Myeloma with 8q24 Abnormality
Hisao Nagoshi et al.
CANCER RESEARCH (2012)
DNA methylation of microRNA genes in multiple myeloma
Kwan Yeung Wong et al.
CARCINOGENESIS (2012)
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Maria T. Di Martino et al.
CLINICAL CANCER RESEARCH (2012)
Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress
Liang Chu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
BLIMP-1 and STAT3 Counterregulate MicroRNA-21 during Plasma Cell Differentiation
Nicholas A. Barnes et al.
JOURNAL OF IMMUNOLOGY (2012)
Imaging of Multiple Myeloma and Related Plasma Cell Dyscrasias
Ronald C. Walker et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Ryszard Kole et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Long non-coding RNAs and cancer: a new frontier of translational research?
R. Spizzo et al.
ONCOGENE (2012)
The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma
D. Ronchetti et al.
BLOOD CANCER JOURNAL (2012)
Epigenetic inactivation of the MIR34B/C in multiple myeloma
Kwan Yeung Wong et al.
BLOOD (2011)
Epigenetic silencing of MIR203 in multiple myeloma
Kwan-Yeung Wong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Molecular Mechanisms of Long Noncoding RNAs
Kevin C. Wang et al.
MOLECULAR CELL (2011)
MicroRNA signatures characterize multiple myeloma patients
S. L. Corthals et al.
LEUKEMIA (2011)
Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
Mu Hao et al.
LEUKEMIA & LYMPHOMA (2011)
Role for MicroRNAs in Regulating Glucocorticoid Response and Resistance in Multiple Myeloma
Michael A. Tessel et al.
Hormones & Cancer (2011)
Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling
N. C. Gutierrez et al.
LEUKEMIA (2010)
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
Marta Lionetti et al.
BLOOD (2009)
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
Aldo M. Roccaro et al.
BLOOD (2009)
Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells
Marina Chekulaeva et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA
Wenqiang Yu et al.
NATURE (2008)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
Dennis Loeffler et al.
BLOOD (2007)
Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling
Wee J. Chng et al.
CANCER RESEARCH (2007)
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation
N Giuliani et al.
BLOOD (2005)
Molecular pathogenesis and a consequent classification of multiple myeloma
PL Bergsagel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Plasma cell differentiation and multiple myeloma
M Shapiro-Shelef et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
CS Debes-Marun et al.
LEUKEMIA (2003)
In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway
M Chatterjee et al.
BLOOD (2002)
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
PI Croucher et al.
BLOOD (2001)
Share Paper
